Table 4.
Variables | Uni HR | 95% CI | p-value | Multi HR | 95% CI | p-value |
---|---|---|---|---|---|---|
Age | ||||||
<60 | 1 | |||||
≥60 | 1.22 | 0.88–1.68 | 0.23 | |||
Sex | ||||||
Male | 1 | |||||
Female | 0.80 | 0.54–1.19 | 0.26 | |||
Marital | ||||||
Married | 1 | 0.91 | ||||
Unmarried | 1.06 | 0.43–2.58 | ||||
BMI | ||||||
BMI<18.5 | 1 | 0.89 | ||||
18.5≥BMI<25 | 0.83 | 0.40–1.72 | ||||
BMI≥25 | 0.74 | 0.35–1.55 | ||||
Smoking History | ||||||
No | 1 | |||||
Yes | 1.13 | 0.80–1.59 | 0.49 | |||
Smoking Index | ||||||
<800 | 1 | |||||
≥800 | 1.17 | 0.84–1.64 | 0.35 | |||
KPS | ||||||
≥90 | 1 | |||||
<90 | 1.13 | 0.82–1.57 | 0.45 | |||
T Stage | ||||||
T1-T2 | 1 | 1 | ||||
T3-T4 | 1.67 | 1.19–2.30 | 0.003 | 1.60 | 1.13–2.28 | 0.008 |
N Stage | ||||||
N0-N2 | 1 | |||||
N3 | 1.36 | 0.98–1.87 | 0.068 | |||
Brain Metastasis | ||||||
No | 1 | |||||
Yes | 1.18 | 0.83–1.67 | 0.37 | |||
Liver Metastasis | ||||||
No | 1 | |||||
Yes | 1.51 | 1.06–2.15 | 0.022 | |||
Bone Metastasis | ||||||
No | 1 | |||||
Yes | 0.81 | 0.56–1.16 | 0.25 | |||
Thoracic Radiotherapy | ||||||
No | 1 | 1 | ||||
Yes | 0.46 | 0.32–0.67 | <0.001 | 0.45 | 0.32–0.66 | <0.001 |
Pre-ALB | ||||||
≤40 | 1 | |||||
>40 | 0.74 | 0.52–1.06 | 0.099 | |||
Pre-ALP | ||||||
≤100 | 1 | |||||
>100 | 1.36 | 0.98–1.89 | 0.064 | |||
Pre-AAPR | ||||||
≤0.52 | 1 | |||||
>0.52 | 0.64 | 0.46–0.91 | 0.012 | |||
Post-ALB | ||||||
≤40 | 1 | |||||
>40 | 0.78 | 0.55–1.10 | 0.153 | |||
Post-ALP | ||||||
≤100 | 1 | |||||
>100 | 1.49 | 1.04–2.12 | 0.028 | |||
Post-AAPR | ||||||
≤0.52 | 1 | 1 | ||||
>0.52 | 0.52 | 0.38–0.73 | <0.001 | 0.62 | 0.44–0.86 | 0.005 |
Abbreviations: AAPR, albumin-to-alkaline phosphatase ratio; BMI, body mass index; HR, hazard ratios; KPS, Karnofsky performance score; OS, overall survival.